{"id":28161,"date":"2024-05-20T22:05:00","date_gmt":"2024-05-20T22:05:00","guid":{"rendered":"https:\/\/pickbydoc.com\/240520180527-htm\/"},"modified":"2024-05-20T22:05:00","modified_gmt":"2024-05-20T22:05:00","slug":"240520180527-htm","status":"publish","type":"post","link":"https:\/\/pickbydoc.com\/?p=28161","title":{"rendered":"Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation"},"content":{"rendered":"<p>Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug &#8212; dupilumab &#8212; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report. This monoclonal antibody is the first biologic shown to improve clinical outcomes in COPD.<\/p>\n<hr>\n<p>\n<strong>Source:<\/strong><br \/>\n<a href=\"https:\/\/www.sciencedaily.com\/releases\/2024\/05\/240520180527.htm\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\nwww.sciencedaily.com<br \/>\n<\/a>\n<\/p>\n<p style=\"font-size:13px;color:#666;\">\n<strong>Medical Disclaimer:<\/strong><br \/>\nThis content is shared for informational and educational purposes only.<br \/>\nIt does not constitute medical, legal, or policy advice.<br \/>\nHealthcare decisions should always be made in consultation with qualified professionals.\n<\/p>\n<p><br \/>\n<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug &#8212; dupilumab &#8212; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report. This monoclonal antibody is the first biologic shown to improve clinical outcomes in COPD. Source: www.sciencedaily.com Medical Disclaimer: [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":28162,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[171],"tags":[16846,13771,2226,18892,4591,18208,12856,18891,11284,14133,9327],"class_list":["post-28161","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-conditions","tag-clinical","tag-copd","tag-disease","tag-dupilumab","tag-inflammation","tag-lessens","tag-patients","tag-phase","tag-shows","tag-trial","tag-type"],"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/posts\/28161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28161"}],"version-history":[{"count":0,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/posts\/28161\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/media\/28162"}],"wp:attachment":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}